Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2

Conditions

Lung Neoplasms 4Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 3Pituitary Neoplasms 2Liver Neoplasms 2Carcinoma, Neuroendocrine 2Adrenal Gland Neoplasms 2Thyroid Carcinoma, Anaplastic 1Paraganglioma 1Neurofibroma 1Neuroendocrine Tumors 1Neurilemmoma 1Meningioma 1Hypopituitarism 1Growth Hormone-Secreting Pituitary Adenoma 1Gastro-enteropancreatic neuroendocrine tumor 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Arteriovenous Malformations 1Anal Canal Carcinoma 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1Acromegaly 1

Interventions

pasireotide 7Cabergoline 7Surgical Procedures, Operative 4Temozolomide 3Propofol 3Hydrocortisone 3Dexmedetomidine 3lanreotide 2Sevoflurane 2Saline Solution 2Rosiglitazone 2Radiotherapy 2Radiosurgery 2Proton Therapy 2Octreotide 2Human Growth Hormone 2Dexamethasone 2Desflurane 2Aminolevulinic Acid 2pegvisomant 1parecoxib 1lutetium Lu 177 dotatate 1loxoprofen 1farletuzumab 1entinostat 1corticorelin ovine 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Visual Field Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Radiosurgery × Endocrine × Clear all
NCT07015645 2025-06-11

Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

Al-Azhar University

Completed
137 enrolled
Endocrine

Hypopituitarism, Pituitary Neoplasms

NCT03439709 2018-03-01

MERGE

Samsung Medical Center

Phase 3 Unknown
90 enrolled
Endocrine

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡